Literature DB >> 25573103

Ready to benefit from training: heterologous effects of early life immunization.

Orly Levy1, Ofer Levy2.   

Abstract

Trained immunity reflects the ability of the innate immune system to adapt via epigenetic changes in monocytes, enhancing responses to a range of microbes, thereby potentially reducing infection in high-risk populations. Examples of trained immunity at birth include enhanced resistance to infection in TLR-simulated newborn mice, reduced risk of late onset sepsis with histologic chorioamnionitis and beneficial heterologous effects of neonatal bacille Calmette-Guérin administration in reducing diverse infections during infancy. Future efforts will assess leveraging trained immunity in early life by administering 'stand-alone' innate immune stimuli or (self-)adjuvanted vaccines to protect against a broad range of infections.
© The Author 2015. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Heterologous immunity; Infant; Newborn; Non-specific effect; Trained immunity; Vaccine

Mesh:

Substances:

Year:  2015        PMID: 25573103      PMCID: PMC4351359          DOI: 10.1093/trstmh/tru185

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  13 in total

1.  Mycobacterium indicus pranii and Mycobacterium bovis BCG lead to differential macrophage activation in Toll-like receptor-dependent manner.

Authors:  Pawan Kumar; Rohit Tyagi; Gobardhan Das; Sangeeta Bhaskar
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

2.  Saving lives by training innate immunity with bacille Calmette-Guerin vaccine.

Authors:  Peter Aaby; Christine Stabell Benn
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

3.  Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes.

Authors:  Johanneke Kleinnijenhuis; Jessica Quintin; Frank Preijers; Leo A B Joosten; Daniela C Ifrim; Sadia Saeed; Cor Jacobs; Joke van Loenhout; Dirk de Jong; Hendrik G Stunnenberg; Ramnik J Xavier; Jos W M van der Meer; Reinout van Crevel; Mihai G Netea
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

4.  Histologic chorioamnionitis is associated with reduced risk of late-onset sepsis in preterm infants.

Authors:  Tobias Strunk; Dorota Doherty; Angela Jacques; Karen Simmer; Peter Richmond; Rolland Kohan; Adrian Charles; David Burgner
Journal:  Pediatrics       Date:  2011-12-12       Impact factor: 7.124

5.  Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections.

Authors:  Signe Sørup; Christine S Benn; Anja Poulsen; Tyra G Krause; Peter Aaby; Henrik Ravn
Journal:  JAMA       Date:  2014-02-26       Impact factor: 56.272

6.  Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists.

Authors:  James L Wynn; Philip O Scumpia; Robert D Winfield; Matthew J Delano; Kindra Kelly-Scumpia; Tolga Barker; Ricardo Ungaro; Ofer Levy; Lyle L Moldawer
Journal:  Blood       Date:  2008-06-30       Impact factor: 22.113

7.  Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000.

Authors:  Li Liu; Hope L Johnson; Simon Cousens; Jamie Perin; Susana Scott; Joy E Lawn; Igor Rudan; Harry Campbell; Richard Cibulskis; Mengying Li; Colin Mathers; Robert E Black
Journal:  Lancet       Date:  2012-05-11       Impact factor: 79.321

Review 8.  Innate immune memory: implications for development of pediatric immunomodulatory agents and adjuvanted vaccines.

Authors:  Ofer Levy; Mihai G Netea
Journal:  Pediatr Res       Date:  2013-11-06       Impact factor: 3.756

9.  The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes.

Authors:  David J Dowling; Zhen Tan; Zofia M Prokopowicz; Christine D Palmer; Maura-Ann H Matthews; Gregory N Dietsch; Robert M Hershberg; Ofer Levy
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

Review 10.  Soluble mediators regulating immunity in early life.

Authors:  Matthew Aaron Pettengill; Simon Daniël van Haren; Ofer Levy
Journal:  Front Immunol       Date:  2014-09-24       Impact factor: 7.561

View more
  8 in total

1.  Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG Vaccine.

Authors:  Kara Jensen; Myra Grace Dela Pena-Ponce; Michael Piatak; Rebecca Shoemaker; Kelli Oswald; William R Jacobs; Glenn Fennelly; Carissa Lucero; Katie R Mollan; Michael G Hudgens; Angela Amedee; Pamela A Kozlowski; Jacob D Estes; Jeffrey D Lifson; Koen K A Van Rompay; Michelle Larsen; Kristina De Paris
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

Review 2.  Vaccine responses in newborns.

Authors:  Anja Saso; Beate Kampmann
Journal:  Semin Immunopathol       Date:  2017-11-09       Impact factor: 9.623

Review 3.  Heterologous effects of infant BCG vaccination: potential mechanisms of immunity.

Authors:  Egle Butkeviciute; Christine E Jones; Steven G Smith
Journal:  Future Microbiol       Date:  2018-08-17       Impact factor: 3.165

4.  Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves.

Authors:  Mariana Guerra-Maupome; Dua X Vang; Jodi L McGill
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

5.  An autophagy-inducing and TLR-2 activating BCG vaccine induces a robust protection against tuberculosis in mice.

Authors:  Arshad Khan; Pearl Bakhru; Subramanian Dhandayuthapani; Chinnaswamy Jagannath; Sankaralingam Saikolappan; Kishore Das; Emily Soudani; Christopher R Singh; Jaymie L Estrella; Dekai Zhang; Chandrashekhar Pasare; Yue Ma; Jianjun Sun; Jin Wang; Robert L Hunter; N Tony Eissa
Journal:  NPJ Vaccines       Date:  2019-08-05       Impact factor: 7.344

Review 6.  Innate Immunomodulation in Food Animals: Evidence for Trained Immunity?

Authors:  Kristen A Byrne; Crystal L Loving; Jodi L McGill
Journal:  Front Immunol       Date:  2020-06-05       Impact factor: 7.561

Review 7.  Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game.

Authors:  Jean-Louis Palgen; Yanis Feraoun; Gaëlle Dzangué-Tchoupou; Candie Joly; Frédéric Martinon; Roger Le Grand; Anne-Sophie Beignon
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

8.  Differential induction of innate memory in porcine monocytes by β-glucan or bacillus Calmette-Guerin.

Authors:  Kristen A Byrne; Christopher K Tuggle; Crystal L Loving
Journal:  Innate Immun       Date:  2020-08-30       Impact factor: 2.680

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.